{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:06Z","timestamp":1786987026130,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["33183\u2013154\u201304-95"],"award-info":[{"award-number":["33183\u2013154\u201304-95"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clim.2021.108826","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:07:28Z","timestamp":1629338848000},"page":"108826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin"],"prefix":"10.1016","volume":"230","author":[{"given":"Hossein","family":"Esmaeilzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Askarisarvestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Alireza","family":"Mahdaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Chavoshzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazdak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Khakbazanfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz Sadeghi","family":"Shabestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Aleyasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hesamedin","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akefeh","family":"Ahmadiafshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Eslamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasol","family":"Molatefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Shirkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Heidarzadeh Arani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Tavakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Bemanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Arshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Shahhosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooria","family":"Nakhaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Fallahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ahanchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Moazzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khoshkhui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Vosughi","family":"Motlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2021.108826_bb0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS Phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2021.108826_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.09.004","article-title":"Comparison of common monogenic defects in a large predominantly antibody deficiency cohort","volume":"7","author":"Yazdani","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.clim.2021.108826_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18176\/jiaci.0166","article-title":"Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders","volume":"27","author":"Yazdani","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.clim.2021.108826_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1871530316666160724214418","article-title":"The use of immunoglobulin therapy in primary immunodeficiency diseases","volume":"16","author":"Azizi","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"10.1016\/j.clim.2021.108826_bb0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.iac.2015.07.006","article-title":"Immunoglobulin replacement therapy for primary immunodeficiency","volume":"35","author":"Sriaroon","year":"2015","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"7","key":"10.1016\/j.clim.2021.108826_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1398-9995.2003.00239.x","article-title":"IVIG--mechanisms of action","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","article-title":"Adverse effects of human immunoglobulin therapy","volume":"27","author":"Stiehm","year":"2013","journal-title":"Transfus. Med. Rev."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0045","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","article-title":"The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature","volume":"129","author":"Rachid","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf."},{"issue":"10","key":"10.1016\/j.clim.2021.108826_bb0055","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion."},{"issue":"1","key":"10.1016\/j.clim.2021.108826_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/17512433.2016.1105131","article-title":"Managing patients with side effects and adverse events to immunoglobulin therapy","volume":"9","author":"Azizi","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2021.108826_bb0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s10875-012-9720-1","article-title":"Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis","volume":"32","author":"Abolhassani","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2021.108826_bb0075","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1586\/1744666X.2015.1079485","article-title":"Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?","volume":"11","author":"Abolhassani","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108826_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01541739","article-title":"Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at home","volume":"15","author":"Brennan","year":"1995","journal-title":"J. Clin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2021.108826_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0248-8663(03)00137-1","article-title":"Intravenous immunoglobulin (Endobulin) clinical tolerance: prospective therapeutic follow-up of 142 adults and children","volume":"24","author":"Pautard","year":"2003","journal-title":"Rev. Med. Interne"},{"issue":"10","key":"10.1016\/j.clim.2021.108826_bb0090","first-page":"953","article-title":"Adverse reactions of intravenous immunoglobulin","volume":"21","author":"Al-Wahadneh","year":"2000","journal-title":"Saudi Med J."},{"issue":"10","key":"10.1016\/j.clim.2021.108826_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00043426-200310000-00011","article-title":"Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial","volume":"25","author":"Benesch","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.clim.2021.108826_bb0100","first-page":"139","article-title":"Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases","volume":"19","author":"Dashti-Khavidaki","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"10.1016\/j.clim.2021.108826_bb0105","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.clim.2021.108826_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","article-title":"Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin","volume":"133","author":"Brennan","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2021.108826_bb0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.aller.2020.05.008","article-title":"Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement","volume":"48","author":"Ibis","year":"2020","journal-title":"Allergol. Immunopathol."},{"issue":"7","key":"10.1016\/j.clim.2021.108826_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10875-018-0556-1","article-title":"Fourth update on the Iranian National Registry of primary Immunodeficiencies: integration of molecular diagnosis","volume":"38","author":"Abolhassani","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2021.108826_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/adc.2005.078733","article-title":"A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions","volume":"91","author":"Singh-Grewal","year":"2006","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.clim.2021.108826_bb0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-012-9656-5","article-title":"Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency","volume":"32","author":"Wasserman","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108826_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227796","article-title":"Predictive factors of first dosage intravenous immunoglobulin-related adverse effects in children","volume":"15","author":"Kubota","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clim.2021.108826_bb0140","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.intimp.2014.09.015","article-title":"Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions","volume":"23","author":"Bichuetti-Silva","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.clim.2021.108826_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.24953\/turkjped.2020.03.004","article-title":"Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience","volume":"62","author":"Nain","year":"2020","journal-title":"Turk. J. Pediatr."},{"issue":"1","key":"10.1016\/j.clim.2021.108826_bb0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1081-1206(10)61711-5","article-title":"Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency","volume":"92","author":"Aghamohammadi","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4 Suppl","key":"10.1016\/j.clim.2021.108826_bb0155","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency Committee of the American Academy of allergy, asthma and immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:30Z","timestamp":1761494670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"alternative-id":["S1521661621001637"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108826","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108826"}}